HC Wainwright & Co. Maintains Buy on Precigen, Raises Price Target to $9
Benzinga Newsdesk 12 months ago
NewsPrice TargetAnalyst Ratings
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Precigen (NASDAQ:PGEN) with a Buy and raises the price target from $8.5 to $9.
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Precigen (NASDAQ:PGEN) with a Buy and raises the price target from $8.5 to $9.